Method for creating animal pharmacokinetic model for drug multi-peak phenomenon

A technology of mechanical models and construction methods, applied in the direction of scientific instruments, measuring devices, instruments, etc., can solve problems affecting the evaluation of effects and safety, toxic and side effects, and impact

Active Publication Date: 2019-11-22
SUN YAT SEN UNIV
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented technology allows scientists to study how different types of medication work together more accurately than previously possible due to their smaller size compared to other methods like simulators or simulations. By comparing these models against existing data from clinicians we aimed at developing new ways to improve understanding about treatments based on multiple modes such as behavior-based therapy, gene editing, chemotherapies, etc., making them better suited for use by veterinary professionals worldwide.

Problems solved by technology

This patented describes how different types of medicines behave differently when given together. It suggests that there may exist some combinations between them called “multidomics” where they act more like one another than just two things alone. These techniques help predict whether any combination works well on humans without causing harmful reactions even if those same chemical compounds were administered simultaneously.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for creating animal pharmacokinetic model for drug multi-peak phenomenon
  • Method for creating animal pharmacokinetic model for drug multi-peak phenomenon
  • Method for creating animal pharmacokinetic model for drug multi-peak phenomenon

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0035] Naringin is a flavonoid compound, the main form of existence in the body is naringin and the active metabolite naringenin, and multi-peak phenomenon occurs in dogs, and the dog pharmacokinetics for multi-peak phenomenon can be established by using the present invention model, and calculate the pharmacokinetic parameters.

[0036]1. Instruments: 1 / 100,000 electronic analytical balance (MS205DU, Mettler toledo, Switzerland); ultrapure water device (Simplicity, Millipore, USA); CNC ultrasonic cleaner (KQ250DE, Kunshan Ultrasonic Instrument Co., Ltd.); 1200SL HPLC-6410A Triple Quad Liquid Chromatography-Mass Spectrometry Instrument, Agilent, USA; Centrifuge 5430R Desktop High-speed Refrigerated Centrifuge, Eppendorf, Germany; Vortex-Genie 2 Vortex Oscillator, Scientific Industries, USA; series of precision pipettes , American Rainin Company; chromatographic column: Agilent RRHT ZORBAX Eclipse C18 column (2.1×100 mm, 1.8 μm).

[0037] 2. Standard product: Naringin standard ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a method for creating an animal pharmacokinetic model for a drug multi-peak phenomenon. The method includes the following steps: selecting at least 6 dogs with three male dogsand three female dogs, carrying out dosing based on a certain dosage, collecting blood samples after dosing, for a blood sample time point, at least collecting two block sampling points before a first peak, at least collecting three blood sampling points near a highest value of each peak, and at least collecting three blood sampling points after a last peak; measuring the blood drug concentrationby using a liquid mass spectrometer; and calculating a fitting constant (DM) for five types of each dog and indicating a minimum value to be a pharmacokinetic standard model class of the dog. According to the invention, the standard model can be established in the dog, the pharmacokinetic parameters of the drug are calculated correctly, and thus a reasonable dosing plan is provided. The method also can be used for calculating and predicting the drug concentration of the drug in the dog, so that a defect of excessive dog dosing amount due to the small pharmacokinetic parameters of the drug formulti-peak phenomenon calculation by the existing pharmacokinetic software is overcome.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products